Trial Profile
A Single-center, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Samidorphan in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Sep 2018
Price :
$35
*
At a glance
- Drugs Samidorphan (Primary)
- Indications Alcoholism; CNS disorders; Eating disorders; Substance-related disorders
- Focus Adverse reactions; Pharmacokinetics
- 01 Sep 2018 Results published in the Clinical Pharmacology in Drug Development
- 13 Oct 2015 New trial record